基于营养和微生物群的方法治疗肌缩侧面硬化症:从预防到治疗
Francesca Cuffaro1, Ingrid Lamminpää2, Elena Niccolai1,2
1Division of Interdisciplinary Internal Medicine, Careggi University Hospital of Florence, 50134 Florence, Italy.
Nutrients
|January 11, 2025
概括
代谢和肠道问题加剧了肌缩侧面硬化症 (ALS). 营养和肠道微生物群干预措施有望减缓疾病进展并改善患者的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 代谢科学 代谢科学
- 胃肠病学 胃肠病学
背景情况:
- 像超高代谢和葡萄糖失调等代谢变化是肌缩侧面硬化症 (ALS) 发病的关键驱动因素.
- 胃肠道功能障碍和肠道微生物群 (GM) 功能障碍通过促进免疫失调和神经炎症而加剧ALS.
- 这些相互关联的因素有助于系统能量赤字,氧化应激和神经退行.
研究的目的:
- 审查代谢和肠道微生物群改变在ALS进展中的作用.
- 探索针对ALS治疗的营养和微生物群向疗法的潜力.
- 强调需要个性化战略,整合免疫营养和微生物群调节.
主要方法:
- 对代谢变化,肠道微生物群及其对ALS的影响研究的文献综述.
- 对饮食干预措施 (例如地中海饮食) 和基于微生物群的方法 (益生菌,益生菌,FMT) 的证据分析.
- 在ALS的背景下,对肠-大脑轴 (GBA) 的发现进行综合.
主要成果:
- 富含抗氧化剂和omega-3脂肪酸的饮食可能会减少ALS中的氧化应激和炎症.
- 针对微生物群的疗法显示出恢复微生物平衡和肠道完整性的潜力.
- 通过这些干预措施优化GBA功能可能有助于减缓神经退行.
结论:
- 个性化免疫营养和微生物群调节策略对于减缓ALS进展至关重要.
- 基于饮食和微生物群的干预措施为ALS提供了有希望的治疗和预防途径.
- 需要进一步的研究,以建立这些干预措施的基于证据的指导方针.
相关概念视频
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444


